Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy

BACKGROUND: The optimal dose of radioactive iodine (RAI) therapy for N1b papillary thyroid carcinoma (PTC) is controversial. We evaluated the clinical outcome of N1b PTC patients treated with either 100 or 150 mCi of RAI. METHODS: We retrospectively analyzed N1b PTC patients who underwent total thyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Meihua, Ahn, Jonghwa, Lee, Yu-Mi, Sung, Tae-Yon, Kim, Won Gu, Kim, Tae Yong, Ryu, Jin-Sook, Kim, Won Bae, Shong, Young Kee, Jeon, Min Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520585/
https://www.ncbi.nlm.nih.gov/pubmed/32981302
http://dx.doi.org/10.3803/EnM.2020.741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520585/
https://www.ncbi.nlm.nih.gov/pubmed/32981302
http://dx.doi.org/10.3803/EnM.2020.741

Ejemplares similares